Medical Debt Relief Act of 2025
The Medical Debt Relief Act of 2025 would overhaul how medical debt is treated under federal credit reporting. It adds a formal definition of “medical debt” to the Fair Credit Reporting Act (FCRA) and prohibits the inclusion of medical debt on consumer credit reports. It also removes any adverse information related to medical debt from credit reports (such as collections or charge-offs) and takes steps to ensure that information about a consumer’s medical debt cannot be used by creditors when deciding whether to extend credit. In addition, the bill requires the Consumer Financial Protection Bureau (CFPB) to amend regulations within one year to bar creditors from obtaining or using medical debt information in credit decisions. The overall effect is to shield individuals with medical debt from negative credit reporting and from using that debt in lending decisions.
Key Points
- 1Definition added: The bill defines “medical debt” as debt arising from the receipt of medical services, products, or devices.
- 2Exclusion from credit reporting: Medical debt would be prohibited from being included on a consumer report, and adverse information related to medical debt (including collections or other actions) would be removed from reporting.
- 3Technical amendments: The bill makes conforming changes to existing FCRA provisions to eliminate references to medical debt in reporting. This includes adjustments to where and how medical debt information could appear or be treated.
- 4Regulatory action: Within one year after enactment, the CFPB must amend regulations to ensure creditors are prohibited from obtaining or using medical debt information in deciding whether to extend credit.
- 5Scope and intent: The act targets medical debt specifically and does not remove other types of debt from credit reporting or credit decisions. It positions itself as a consumer protection and debt-relief measure by reducing the impact of medical debt on credit access.